Therapeutic use of anti-CS1 antibodies

Details for Australian Patent Application No. 2010214661 (hide)

Owner Abbott Biotherapeutics Corp.

Inventors Powers, David B.; Liu, Gao; Williams, Marna; Landolfi, Nicolas F.; Tso, Yun J.

Agent Davies Collison Cave

Pub. Number AU-B-2010214661

Parent 2004238363

Filing date 25 August 2010

Wipo publication date 16 September 2010

Acceptance publication date 17 May 2012

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 September 2010 Complete Application Filed

16 September 2010 Application Open to Public Inspection

  Published as AU-B-2010214661

27 January 2011 Alteration of Name

  The name of the applicant has been altered to Abbott Biotherapeutics Corp.

17 May 2012 Application Accepted

  Published as AU-B-2010214661

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214662-Adaptor for a pipe

2010214660-Freight container